What is she best known for?
The fields of study she is best known for:
- Cancer
- Internal medicine
- Gene
Pathology, Radiation therapy, Internal medicine, Oncology and Carcinoma are her primary areas of study.
Her research integrates issues of Cancer research, Hypoxia and microRNA in her study of Pathology.
The study incorporates disciplines such as Prostate cancer and Chemotherapy in addition to Radiation therapy.
Her Internal medicine study combines topics from a wide range of disciplines, such as PI3K/AKT/mTOR pathway, PTEN and Kinase.
Her Oncology study combines topics in areas such as Stage, Breast cancer, Carbogen and Head and neck.
Her Carcinoma research includes elements of Dynamic contrast-enhanced MRI, Metastasis, T1 weighted and Cervix.
Her most cited work include:
- Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. (446 citations)
- Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix. (279 citations)
- Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (268 citations)
What are the main themes of her work throughout her whole career to date?
The scientist’s investigation covers issues in Internal medicine, Oncology, Radiation therapy, Pathology and Cancer research.
Her research in Oncology tackles topics such as Genome-wide association study which are related to areas like Genetic association.
The concepts of her Radiation therapy study are interwoven with issues in Breast cancer and Carcinoma.
Her Carcinoma study integrates concerns from other disciplines, such as Radiology, Nuclear medicine, Cancer staging and Cervix.
Her research ties Adenocarcinoma and Pathology together.
Her Cancer research research is multidisciplinary, incorporating elements of Cancer cell, Endocrinology, Gene and Immunology.
She most often published in these fields:
- Internal medicine (44.72%)
- Oncology (40.54%)
- Radiation therapy (39.31%)
What were the highlights of her more recent work (between 2017-2021)?
- Internal medicine (44.72%)
- Oncology (40.54%)
- Radiation therapy (39.31%)
In recent papers she was focusing on the following fields of study:
Her primary areas of study are Internal medicine, Oncology, Radiation therapy, Prostate cancer and Hypoxia.
Her biological study spans a wide range of topics, including Cancer, Breast cancer, Head and neck cancer and Proportional hazards model.
Her research in Cancer intersects with topics in Multivariate analysis and Nomogram.
Her Radiation therapy study incorporates themes from Bladder cancer, Gene signature, Medical physics and Cohort study.
She interconnects Relative risk, Genome-wide association study, Single-nucleotide polymorphism and Case-control study in the investigation of issues within Prostate cancer.
Her Hypoxia research includes themes of Soft tissue sarcoma, Cancer research, Transcriptome and Bioinformatics.
Between 2017 and 2021, her most popular works were:
- Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (268 citations)
- Targeting Hypoxia to Improve Non-Small Cell Lung Cancer Outcome. (95 citations)
- Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer (52 citations)
In her most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
Catharine M L West mostly deals with Internal medicine, Oncology, Prostate cancer, Radiation therapy and Hypoxia.
Her research investigates the connection between Oncology and topics such as Metastasis that intersect with problems in Tumour heterogeneity, Sarcoma, Tissue microarray and Pathology.
Her Prostate cancer research is multidisciplinary, relying on both Genetic model, Breast cancer, Genome-wide association study and Genotype.
She has included themes like Bladder cancer, Absolute risk reduction, Cohort study, Gene signature and Prospective cohort study in her Radiation therapy study.
Her Hypoxia research incorporates themes from Biomarker, Transcriptome and Bioinformatics.
Catharine M L West combines subjects such as Magnetic resonance imaging, Renal cell carcinoma, Perfusion and Carcinoma with her study of Tumor hypoxia.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
